These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24043968)

  • 1. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography.
    Kim AY; Lee MW; Rhim H; Cha DI; Choi D; Kim YS; Lim HK; Cho SW
    Korean J Radiol; 2013; 14(5):754-63. PubMed ID: 24043968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography.
    Lee MW; Lim HK; Rhim H; Cha DI; Kang TW; Song KD; Min JH; Gwak GY; Kim S; Lu DSK
    Can J Gastroenterol Hepatol; 2018; 2018():7926923. PubMed ID: 30013957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound.
    Kim EJ; Kim YS; Shin SK; Kwon OS; Choi DJ; Kim JH
    Turk J Gastroenterol; 2017 Nov; 28(6):446-452. PubMed ID: 29086712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
    Min JH; Lim HK; Lim S; Kang TW; Song KD; Choi SY; Rhim H; Lee MW
    Clin Mol Hepatol; 2014 Mar; 20(1):61-70. PubMed ID: 24757660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
    Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H
    Hepatogastroenterology; 2015 May; 62(139):661-6. PubMed ID: 26897949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging.
    Minami T; Minami Y; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Inoue T; Hagiwara S; Ueshima K; Nishida N; Kudo M
    Oncology; 2014; 87 Suppl 1():55-62. PubMed ID: 25427734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
    Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography.
    Park HJ; Lee MW; Rhim H; Cha DI; Kang TW; Lim S; Song KD; Lim HK
    Clin Radiol; 2015 Apr; 70(4):387-94. PubMed ID: 25582889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
    Du J; Li HL; Zhai B; Chang S; Li FH
    Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation.
    Ishii T; Numata K; Hao Y; Doba N; Hara K; Kondo M; Tanaka K; Maeda S
    Eur J Radiol; 2017 Apr; 89():234-241. PubMed ID: 28034569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
    Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN
    J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
    Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW
    Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
    Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
    J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
    Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
    Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study.
    Chan AK; Hegarty C; Klass D; Yoshida E; Chung S; Liu DM; Ho SG; Harris AC
    Can Assoc Radiol J; 2015 May; 66(2):171-8. PubMed ID: 25637354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
    Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
    Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiofrequency ablation for viable hepatocellular carcinoma around retained iodized oil after transcatheter arterial chemoembolization: usefulness of biplane fluoroscopy plus ultrasound guidance.
    Min JH; Lee MW; Rhim H; Choi D; Kim YS; Kim YJ; Cha DI; Lim HK
    Korean J Radiol; 2012; 13(6):784-94. PubMed ID: 23118578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasonography-CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome.
    Lee Y; Yoon JH; Han S; Joo I; Lee JM
    Cancer Imaging; 2024 Jan; 24(1):4. PubMed ID: 38172949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography.
    Min JH; Lee MW; Cha DI; Jeon YH; Shin SW; Cho SK; Rhim H; Lim HK
    Korean J Radiol; 2013; 14(2):248-58. PubMed ID: 23483753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.